The Middle EAST Antiobesity Prescription Drug Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.5%. This growth trajectory is underpinned by several factors, including a rising prevalence of obesity, increasing healthcare expenditure, and a growing awareness of obesity-related health issues. According to the World Health...
Portuguese 
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek